UNCY

Conviction 86HealthcareScan · Fri, Jun 26, 2026

UNCY$7.12-13.34%

ResistanceSupportVol 14

Vol MA14 1.57M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Unicycive Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.unicycive.com ↗

Price7.12

Change-13.34%

Gap-0.12%

Rel volume5.26×

Avg volume1.34M

Avg $ vol9.87M

SMA 207.38

SMA 507.55

SMA 2006.23

Price vs 50-5.72%

Price vs 200+14.14%

MA stackmixed

50/200 cross—

Supertrenddown · 8.40

RSI (14)46

MACD hist0.05

MACD crossbull · 4d

Stoch %K / %D24 / 58

ADX (14)16

+DI / −DI22 / 24

RSI divergence—

MACD divergence—

ATR %+9.61%

ADR %8.86%

52w high8.56

52w low3.74

From 52w high-16.88%

Above 52w low+90.24%

New 52w highNo

SqueezeOn · 1d

Bollinger width21.77%

%B0.33

Donchian pos24.35%

Donchian high8.56

Donchian low6.65

AVWAP (52w high)7.51

vs AVWAP high-5.31%

AVWAP (52w low)6.63

vs AVWAP low+7.33%

OBV trendDown

Chaikin MF (20)-0.31

Today vs 20d5.26×

Avg vol (14d)1.57M

Avg vol (20d)1.34M

Avg $ vol (20d)9.87M

Market cap—

RS 3m (vs SPY)+11.66%

RS 6m (vs SPY)+33.12%

RS line new highNo

Trend template7/8

Technical rank63.3

1 week+3.87%

1 month+0.64%

3 months+7.32%

6 months+23.95%

1 year+14.57%

YTD+22.67%

P/E-8.24

P/B5.80

P/S324.16

P/FCF-6.98

EPS-1.67

Div yield0.50%

ROE-70.43%

ROA-41.23%

Debt/Eq—

Current2.40

EV/EBITDA-6.24

Gross margin—

Net margin—

Rev growth0.00%

EPS growth27.70%

Price target41.50

Target upside406.41%

Analyst ratingBuy

Institutional40.14%

Ent. value181.44M

Revenue675K

Net income-12.82M

Gross profit—

Free cash flow-31.34M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out27.39M

Employees22

ListedTue, Jul 13, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction86 / 100

Pattern quality—

Tech rank63.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance8.57

Support6.66

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in UNCY

All disclosures →

No recent disclosed trades by Congress in UNCY. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in UNCY · 8 buys

Insider	Side	Shares	Value	Traded	Filed
Gupta Shalabh K. CEO · Restricted Stock Units · 2026-05-14	Grant	762.2K	$0	2026-05-14	2026-05-21
Kenkare-Mitra Sara Director · Restricted Stock Units · 2026-05-14	Grant	42.1K	$0	2026-05-14	2026-05-21
Kenkare-Mitra Sara Director · Restricted Stock Units · 2026-05-14	Grant	84.2K	$0	2026-05-14	2026-05-21
Gupta Pramod EVP, Pharmaceuticals and BD · Restricted Stock Unit · 2026-05-14	Grant	169.5K	$0	2026-05-14	2026-05-20
Townsend John CFO · Restricted Stock Unit · 2026-05-14	Grant	169.5K	$0	2026-05-14	2026-05-20
Jermasek Douglas EVP, Corporate Strategy · Restricted Stock Units · 2026-05-14	Grant	169.5K	$0	2026-05-14	2026-05-20
Laumas Sandeep Director · Restricted Stock Units · 2026-05-14	Grant	42.1K	$0	2026-05-14	2026-05-18
Laumas Sandeep Director · Restricted Stock Units · 2026-05-14	Grant	84.2K	$0	2026-05-14	2026-05-18

SEC filings

EDGAR filings in UNCY · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.